CLINICAL ECONOMICS OF HEAD AND NECK MALIGNANCIES
- 12 August 1999
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 13 (4) , 867-881
- https://doi.org/10.1016/s0889-8588(05)70098-8
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Costs of conventional radical radiotherapy versus continuous hyperfractionated accelerated radiotherapy (CHART) in the treatment of patients with head and neck cancer or carcinoma of the bronchusClinical Oncology, 1997
- Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.Journal of Clinical Oncology, 1997
- Quality of Life after Surgical Treatment of Cancer of the LarynxAnnals of Otology, Rhinology & Laryngology, 1995
- Follicular Lesions of the ThyroidAnnals of Surgery, 1995
- Cost Analysis of Antibiotic Prophylaxis in Clean Head and Neck SurgeryJAMA Otolaryngology–Head & Neck Surgery, 1995
- Symptom‐directed selective endoscopy and cost containment for evaluation of head and neck cancerHead & Neck, 1993
- Laser Cordectomy or Radiotherapy: Cure Rates, Communication, and CostOtolaryngology -- Head and Neck Surgery, 1993
- Sources of the growth in Medicare physician expendituresPublished by American Medical Association (AMA) ,1992
- How Fast Are Hospital Prices Really Rising?Medical Care, 1991
- Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal CancerNew England Journal of Medicine, 1991